[February 05, 2014] |
|
Reverse Medical® Corporation Announces New Patent for the Micro Vascular Plug (MVP®)
IRVINE, Calif. --(Business Wire)--
Reverse Medical Corporation announced today that the United States
Patent Office has notified the Company that a new patent has issued
entitled "Embolic Implant and Method of Use". This new patent allows
twenty-two claims surrounding the Company's Micro Vascular Plug ("MVP")
technology platform.
The Reverse Medical MVP represents a proprietary technology designed
specifically for vascular embolization. A number of clinical
applications require occlusion of the vasculature to rapidly,
effectively and safely provide blood flow cessation, including
presentations of trauma, hemorrhage, tumor and vascular malformation
isolations. Physicians have traditionally used embolic coils for
vascular embolization, often requiring numerous costly implants,
extensive endovascuar lab time and considerable fluoroscopic radiation
exposure to both the patient and the treating medical staff. The Reverse
Medical MVP represents a breakthrough technology that rapidly occludes
target blood vessels, most often with only one single implant.
Furthermore, the MVP is uniquely deliverable through traditional
microcatheters, allowing the physician to super-selectively perform
rapid vascular embolization at the target vessel location. The MVP
technology platform will be offered in a variety of sizes to treat all
areas of the body's peripheral vasculature.
This newly issued patent builds upon Reverse's intellectual property
portfolio, which now includes six issued patents and thirteen additional
pending patent applications worldwide. Commenting on this new patent,
Reverse Medical Chief Technology Officer Brian Strauss said, "This
patent solidifies our intellectual property foundation of unique means
for performing endovascular embolization and, along with our other
issued patents and pending applications, provides us with broad
protection for our innovative portfolio of devices for treating a
variety of Neuro and Peripheral vascular conditions."
Reverse Medical Corporation is a privately held medical device company
focused on expanding a technology driven pipeline of innovative,
state-of-the-art endovascular treatments for a broad spectrum of
peripheral and neurovascular disorders and diseases. The company is
based in Irvine, California.
[ Back To TMCnet.com's Homepage ]
|